Roche Holding AG (OTCMKTS:RHHVF – Get Free Report)’s stock price rose 4.4% during mid-day trading on Thursday . The stock traded as high as $445.8640 and last traded at $441.7080. Approximately 180 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 12,650 shares. The stock had previously closed at $423.1575.
Roche Stock Performance
The company’s 50-day moving average price is $439.29 and its 200 day moving average price is $419.17.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Read More
- Five stocks we like better than Roche
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
- MarketBeat Week in Review – 09/14 – 09/18
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
